Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes

被引:249
作者
Bellus, GA
Gaudenz, K
Zackai, EH
Clarke, LA
Szabo, J
Francomano, CA
Muenke, M
机构
[1] UNIV PENN,SCH MED,CHILDRENS HOSP PHILADELPHIA,DEPT PEDIAT,DIV HUMAN GENET & MOL BIOL,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,CHILDRENS HOSP PHILADELPHIA,DEPT GENET,PHILADELPHIA,PA 19104
[3] NIH,MED GENET BRANCH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892
[4] JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21287
[5] BRITISH COLUMBIS INST CHILD & FAMILY HLTH,DEPT MED GENET,VANCOUVER,BC V5Z 4H4,CANADA
关键词
D O I
10.1038/ng1096-174
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pfeiffer syndrome (PS; McKusick MIM 101600) is an autosomal dominant craniosynostosis syndrome with characteristic craniofacial anomalies and broad thumbs and big toes. We have previously demonstrated genetic heterogeneity in PS and mapped a gene to chromosome 8 (ref. 3) and a second to chromosome 10 (ref. 4). The gene on chromosome 8 is the fibroblast growth factor receptor 1 (FGFR1) with a common mutation (C755G) predicting a Pro252Arg substitution. The gene on chromosome 10 is FGFR2 with several different mutations causing sporadic and familial PS (Table 1). We report a recurrent single point mutation in the FGFR3 gene, located on chromosome 4p, in ten unrelated families with craniosynostosis syndromes. This mutation (C749G) predicts a Pro250Arg amino acid substitution in the extracellular domain of the FGFR3 protein. Interestingly, this common mutation occurs precisely at the analogous position within the FGFR3 protein as the mutations in FGFR1 (Pro252Arg) and FGFR2 (Pro253Arg) previously reported in Pfeiffer and Apert syndromes, respectively.
引用
收藏
页码:174 / 176
页数:3
相关论文
共 27 条
  • [1] A RECURRENT MUTATION IN THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH-FACTOR RECEPTOR-3 CAUSES HYPOCHONDROPLASIA
    BELLUS, GA
    MCINTOSH, I
    SMITH, EA
    AYLSWORTH, AS
    KAITILA, I
    HORTON, WA
    GREENHAW, GA
    HECHT, JT
    FRANCOMANO, CA
    [J]. NATURE GENETICS, 1995, 10 (03) : 357 - 359
  • [2] PFEIFFER SYNDROME UPDATE, CLINICAL SUBTYPES, AND GUIDELINES FOR DIFFERENTIAL-DIAGNOSIS
    COHEN, MM
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 45 (03): : 300 - 307
  • [3] Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
    Colvin, JS
    Bohne, BA
    Harding, GW
    McEwen, DG
    Ornitz, DM
    [J]. NATURE GENETICS, 1996, 12 (04) : 390 - 397
  • [4] Fibroblast growth factor receptor 3 is a negative regulator of bone growth
    Deng, CX
    WynshawBoris, A
    Zhou, F
    Kuo, A
    Leder, P
    [J]. CELL, 1996, 84 (06) : 911 - 921
  • [5] LOCALIZATION OF CRANIOSYNOSTOSIS ADELAIDE TYPE TO 4P16
    HOLLWAY, GE
    PHILLIPS, HA
    ADES, LC
    HAAN, EA
    MULLEY, JC
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (04) : 681 - 683
  • [6] JOHNSON DE, 1993, ADV CANCER RES, V60, P1
  • [7] FGFR2 MUTATIONS IN PFEIFFER SYNDROME
    LAJEUNIE, E
    MA, HW
    BONAVENTURE, J
    MUNNICH, A
    LEMERRER, M
    RENIER, D
    [J]. NATURE GENETICS, 1995, 9 (02) : 108 - 108
  • [8] EFFECT ON SPLICING OF A SILENT FGFR2 MUTATION IN CROUZON SYNDROME
    LI, X
    PARK, WJ
    PYERITZ, RE
    JABS, EW
    [J]. NATURE GENETICS, 1995, 9 (03) : 232 - 233
  • [9] THE INS AND OUTS OF FIBROBLAST GROWTH-FACTORS
    MASON, IJ
    [J]. CELL, 1994, 78 (04) : 547 - 552
  • [10] MCKUSICK VA, 1994, MENDELIAN INHERITANC, P759